Swanson DGL, 385mg – 180 chewable tablets

Description

Swanson DGL, 385mg – 180 chewable tablets

Achieve optimal digestive integrity with Swanson DGL, a specialized formulation designed to support the stomach’s natural protective mechanisms. This supplement provides a proactive approach to maintaining gastrointestinal comfort and resilience, essential for overall well-being.

Support the stomach’s mucosal lining. Each chewable tablet delivers 385 mg of deglycyrrhizinated licorice (DGL). This specific form of licorice root extract stimulates the natural production of protective mucus in the stomach and esophagus. This mechanism reinforces the mucosal barrier, safeguarding against the effects of digestive acids and promoting a calm, balanced digestive environment.

The chewable format is critical for DGL’s efficacy. Direct contact with oral and esophageal tissues initiates immediate support. This ensures that the active compounds interact precisely where they are needed most, maximizing their protective benefits for the upper digestive tract. This is a targeted delivery system, not merely a convenient consumption method.

Ensure consistent, long-term digestive support. A single container provides 180 chewable tablets, offering a three-month supply based on typical usage. This generous quantity ensures sustained support without frequent reordering, facilitating adherence to a consistent daily regimen for optimal results. The precise 385 mg dosage per tablet allows for controlled and effective supplementation.

Swanson DGL is sourced from the United States, adhering to established manufacturing protocols. This commitment to origin and process ensures product consistency and purity, providing a reliable supplement for daily use. Consumers receive a product developed under stringent quality controls, underpinning its efficacy and safety profile.

Experience assured product freshness and potency. With an expiry date of September 30, 2028, this product guarantees long-term potency. Consumers acquire a supplement with an extended shelf life, ensuring the active compounds remain effective throughout its use. This attention to detail reflects a commitment to delivering a high-quality, stable product.

Swanson DGL is specifically formulated for individuals seeking to proactively maintain digestive health, manage occasional discomfort, or support their immune system through robust gut health. Its targeted action on the gastric mucosa offers a distinct advantage over generic digestive aids. Integrate this supplement into your daily routine to foster a resilient digestive system and enhance your body’s natural defenses.

• Targeted Gastric Support: 385 mg of DGL per tablet specifically aids in strengthening the stomach’s mucosal lining, promoting digestive comfort.
• Chewable Efficacy: Direct contact delivery initiates immediate protective action in the upper digestive tract.
• Extended Supply: 180 tablets provide a three-month regimen for consistent, uninterrupted support.
• Quality Assurance: Manufactured in the United States, ensuring adherence to rigorous production standards.
• Guaranteed Freshness: Expiry date of September 30, 2028, confirms long-term product viability and potency.

Prioritize your digestive health. Swanson DGL offers a scientifically formulated solution for maintaining gastrointestinal balance and fortifying your body’s natural protective barriers.